Aniz Girach, MD, Chief Medical Officer, and Paul Yang, MD, PhD, Casey Eye Institute will discuss which vision measures are most informative in Usher syndrome, the role of baseline and disease progression, and objectives of the Stellar trial.
Hosted by Josh Schimmer at Evercore ISI, this webinar featuring Aniz Girach, MD, Chief Medical Officer takes a deep dive into vision endpoints for IRDs.
Hosted by Josh Schimmer at Evercore ISI, this webinar featuring Aniz Girach, MD, Chief Medical Officer takes a deep dive into vision endpoints for IRDs.
Rare Disease Day takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients' lives.
ARVO 2020 clinical trial results presentation by Stephen Russel et al. Sepofarsen had a manageable safety profile and showed improvement in mean visual acuity, and full-field stimulus testing.
